Related Experiment Videos
Intravitreal ranibizumab in retinal macroaneurysm.
Andrea R Wenkstern1, Heike Petersen
1Eye Center Uzwil, Uzwil, Switzerland. wenkstern@augenarzt-uzwil.ch
Summary
Intravitreal ranibizumab (Lucentis®) therapy effectively treated a patient with retinal macroaneurysm and macular edema, improving vision and reducing retinal thickness. This novel approach shows promise for similar cases.
Area of Science:
- Ophthalmology
- Retinal Vascular Diseases
- Pharmacological Interventions
Background:
- Retinal macroaneurysms can lead to vision-threatening complications like macular edema.
- Current treatment options for retinal macroaneurysms may be limited.
Observation:
- A case report details an 82-year-old female with an inferior temporal artery retinal macroaneurysm and significant macular edema.
- The patient received two intravitreal ranibizumab (Lucentis®) injections followed by focal argon laser treatment.
Findings:
- Significant visual acuity improvement from 20/50 to 20/20 within 3 months.
- Marked reduction in central retinal thickness from 510 µm to 148 µm.
- Successful closure of the retinal macroaneurysm confirmed by fluorescein angiography.
Implications:
- Intravitreal ranibizumab (Lucentis®) demonstrates potential efficacy in closing retinal macroaneurysms.
- This treatment may lead to resolution of macular edema and visual recovery.
- Further research is warranted to explore this therapeutic avenue.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...